Piribo: Marketing ROI for Pharma, new publication announcement

The pharmaceutical landscape is volatile. Research and development costs are soaring, purchasing power is being vested in fewer parties and regulations on pharmaceutical promotion are being tightened. Companies are under greater pressure to control spending and drive profits.

Return on investment (ROI) remains the common mantra from the boardroom downwards. Marketers are being asked to deliver bigger profit margins from diminishing marketing budgets and to demonstrate accountability when making promotional investments. With a better understanding of ROI analysis, pharmaceutical companies can develop and implement more effective marketing communications and enhance profi tability.

The 5th Annual Pharmaceutical Marketing Congress
- Marketing ROI for Pharma
- held in Amsterdam 14-15 November 2005, organised by eyeforpharma, showcased a diverse range of opinion in its attempts to establish best practice. This KeywordPharma Conference Insights review, published by NetworkPharma Ltd, provides analysis of the pertinent issues raised in selected presentations made at the event. It details issues such as how market research can play a major role in informing the decision-making process, and examines why the industry must adopt a more systematic approach to segmentation, targeting and positioning. Critically, it asks whether ROI is actually the best metric for evaluating marketing success.

“Marketing ROI for Pharma” is available from Piribo. For more information go to: http://www.piribo.com/publications/sales_marketing/marketing_roi_pharma.html

Piribo Product ID: NWP003

About Piribo.
Piribo (http://www.piribo.com) is a UK-based independent online store supplying business information on the pharmaceutical and biotechnology industries. The website now carries over 3,800 English language titles including, market reports, studies and books and is the UK’s largest online biopharma information store. Subscribers receive a free monthly newsletter and email alerts on new titles in their areas of interest. The company was established in 2004.